IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma

Abstract : Cholangiocarcinoma (CCA) is a desmoplastic tumor of the biliary tree in which epidermal growth factor receptor (EGFR) is overexpressed and contributes to cancer progression. Although, EGFR has been envisaged as a target for therapy, treatment with tyrosine kinase inhibitors (TKI) such as erlotinib did not provide therapeutic benefit in patients with CCA, emphasizing the need to investigate resistance mechanisms against EGFR inhibition.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01808092
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, June 5, 2018 - 2:16:33 PM
Last modification on : Sunday, November 10, 2019 - 8:56:02 PM

Links full text

Identifiers

Citation

Javier Vaquero, Cindy Lobe, Sylvana Tahraoui, Audrey Clapéron, Martine Mergey, et al.. IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma. Clinical Cancer Research, American Association for Cancer Research, 2018, 24 (17), pp.4282-4296. ⟨10.1158/1078-0432.CCR-17-3725⟩. ⟨hal-01808092⟩

Share

Metrics

Record views

71